Explore daily insights on
Solara Active Pharma surges 14.2% on 37.9x average volume after Q4 record revenue
- Solara Active Pharma Sciences (SOLARA.NS) gained 14.2% on May 14, closing at ₹579.90, as Q4 FY2026 earnings showed record revenue and EBITDA growth
- Volume hit 4.01 million shares — 37.9x the 20-day average of 105,822 — reflecting elevated trading activity
- The stock sits at ₹580 within a 52-week range of ₹422–₹734, recovering from near its annual low
Supporting datasets
Supporting queries
To surface this insight, Baselight ran 6 queries across its structured data. Each one is reproducible — open it, read the SQL, and rerun it yourself.
Conclusion
daily_prices (SOLARA.NS: May 14 close ₹579.90, open ₹507.70, volume 4,013,707); 20-day avg volume 105,822 (computed from daily_prices Apr 10–May 13); vol ratio = 37.9x; news (Business Standard May 15: Q4 2026 revenue ₹387.29 Cr (+41.86% YoY), EBITDA ₹61.7 Cr (+21% YoY), net profit ₹9.60 Cr vs loss ₹2.10 Cr YoY). 52w range: ₹422–₹734.